Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Eastnine | EAST | Nov 21, 2024 | 42.79 | +1.88 |
EasyFill B | EASYB | Nov 21, 2024 | 0.17 | +4.17 |
EatGood | EATG | Nov 21, 2024 | 0.44 | +0.68 |
eBlitz Group | EBLITZ | Nov 21, 2024 | 1.20 | 0.00 |
Ecoclime Group B | ECCB | Nov 21, 2024 | 1.92 | -4.25 |
ECOMB | ECOM | Nov 21, 2024 | 0.12 | +8.22 |
EcoRub B | ECOB | Nov 21, 2024 | 0.13 | +4.72 |
Edyoutec AB | EDYOU | Nov 21, 2024 | 0.95 | -6.42 |
eEducation Albert | ALBERT | Nov 21, 2024 | 3.70 | +1.09 |
Eevia Health | EEVIA | Nov 21, 2024 | 0.25 | 0.00 |
Effnetplattformen Holding | EFFH | Nov 21, 2024 | 4.20 | 0.00 |
Egetis Therapeutics | EGTX | Nov 21, 2024 | 5.40 | -0.55 |
Elanders B | ELANB | Nov 21, 2024 | 87.80 | -0.34 |
Electrolux A | ELUXA | Nov 21, 2024 | 97.00 | -3.00 |
Electrolux B | ELUXB | Nov 21, 2024 | 79.98 | -1.62 |
Electrolux Professional B | EPROB | Nov 21, 2024 | 64.00 | +1.27 |
Elekta B | EKTAB | Nov 21, 2024 | 61.80 | -0.48 |
Elicera Therapeutics | ELIC | Nov 21, 2024 | 1.76 | -1.40 |
Ellen | ELN | Nov 21, 2024 | 1.06 | 0.00 |
Ellwee | ELLWEE | Nov 21, 2024 | 4.13 | +2.99 |
Elmera Group | ELMRAO | Nov 21, 2024 | 38.05 | -2.69 |
Elon AB (publ) | ELON | Nov 21, 2024 | 24.60 | -2.38 |
Eltel | ELTEL | Nov 21, 2024 | 6.54 | -2.39 |
Embark Group | EMB | Nov 21, 2024 | 0.44 | -0.89 |
EmbeddedArt Group AB (publ) | EMART | Nov 21, 2024 | 7.95 | +7.87 |
Embellence Group | EMBELL | Nov 21, 2024 | 30.40 | 0.00 |
Embracer Group B | EMBRACB | Nov 21, 2024 | 27.50 | -3.51 |
Emilshus | EMILPREF | Nov 21, 2024 | 29.90 | -1.32 |
Emilshus B | EMILB | Nov 21, 2024 | 43.80 | -0.45 |
Enad Global 7 | EG7 | Nov 21, 2024 | 13.00 | +1.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.